Home532296 • BOM
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,406.55
Day range
₹1,388.25 - ₹1,498.80
Year range
₹883.50 - ₹1,830.05
Market cap
395.32B INR
Avg Volume
37.08K
P/E ratio
-
Dividend yield
0.18%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 33.88B | 35.14% |
Operating expense | 18.26B | -0.24% |
Net income | 3.48B | 199.03% |
Net profit margin | 10.27 | 173.25% |
Earnings per share | 20.73 | — |
EBITDA | 5.73B | 302.61% |
Effective tax rate | 23.73% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.20B | 61.94% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 84.45B | — |
Shares outstanding | 282.21M | — |
Price to book | 2.35 | — |
Return on assets | — | — |
Return on capital | 11.67% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 3.48B | 199.03% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Founded
Nov 18, 1977
Website
Employees
14,989
